0001958956-22-000001.txt : 20221222 0001958956-22-000001.hdr.sgml : 20221222 20221222133810 ACCESSION NUMBER: 0001958956-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221222 DATE AS OF CHANGE: 20221222 EFFECTIVENESS DATE: 20221222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aethon Therapeutics, Inc. CENTRAL INDEX KEY: 0001958956 IRS NUMBER: 884215231 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-468421 FILM NUMBER: 221481389 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 857-352-3657 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 D 1 primary_doc.xml X0708 D LIVE 0001958956 Aethon Therapeutics, Inc. 230 PARK AVENUE SUITE 2800 NEW YORK NY NEW YORK 10169 857-352-3657 DELAWARE None None Corporation true 2022 Rajesh Chopra c/o Aethon Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Paul Da Silva Jardine c/o Aethon Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Seth Harrison c/o Aethon Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director William Engels c/o Aethon Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Biotechnology Decline to Disclose 06b false 2022-12-16 false true false 0 30000000 6000000 24000000 false 2 0 0 0 false Aethon Therapeutics, Inc. /s/ Rajesh Chopra Rajesh Chopra Chief Executive Officer 2022-12-22